The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
MOUNTAIN VIEW, Calif., May 19, 2011 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM), a complete human genome sequencing company that has developed and commercialized an innovative DNA ...
ST. LOUIS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced successful first ...
OCALA, Fla., Jan. 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has received authorization from the Erasmus Medical Center ...
OCALA, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (AIM) (NYSE American: AIM) (“AIM” or the “Company”) today announced Safety Committee approval to proceed with the Phase 2 portion of ...
Milan, 24 th October 2024 – The Politecnico di Milano and the Erasmus Medical Center in Rotterdam pooled their medical and technical expertise to create a new technology for devices called ...
2022 JAN 24 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- New research on Health and Medicine - Health Policy is the subject of a report. According to news reporting ...
DURHAM, N.C. & ROTTERDAM, The Netherlands--(BUSINESS WIRE)--GeneCentric Therapeutics, Inc. and Erasmus University Medical Center (EUMC) today announced that they have entered into a research ...
AMSTELVEEN, Netherlands--(BUSINESS WIRE)--Hewlett Packard Enterprise (HPE) today announced it is delivering an enhanced hybrid workplace experience with its Virtual Desktop Infrastructure (VDI) ...
2020 JAN 16 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- Investigators publish new report on Economics - Healthcare Economics. According to news reporting originating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results